Tissue Bank In The Department of Pathology
View Larger

Jonathan Pollack

Academic Appointments

Professional Snapshot

Postdoctoral Advisees

Ilona Holcomb , Stephanie Huang , Kevin Kwei

Graduate & Fellowship Program Affiliations

Scientific Focus

Research Interests

Our laboratory uses genomic approaches to systematically characterize the molecular phenotypes of tumor cells, with current efforts in leukemia, breast, prostate, lung, colon and pancreatic cancers. We have found that patterns of gene expression describe the physiologic state of tumor cells, reveal activated signal transduction pathways, and define the likely normal cell types from which tumors have arisen. Patterns of gene expression also suggest improved markers for clinical diagnosis and prognostication, which we are validating by immunohistochemistry on tissue microarrays. In concert, we are profiling gene expression in human cancer cell line model systems in which specific genes or pathways have been altered genetically or pharmacologically, in order to better understand the role of these pathways in oncogenesis.

We have also developed a novel use for cDNA microarrays in measuring gene copy number alteration. The amplification of oncogenes and deletion of tumor suppressor genes, the result of genetic instability, play a critical role in the development of cancer. Co-hybridizing differentially labeled tumor and normal genomic DNA (the principle of comparative genomic hybridization, or CGH) to DNA microarrays permits the high-resolution, genome-wide mapping of gene copy number changes in cancer. These array CGH analyses have led to the identification of numerous regions of recurrent gene amplification and deletion, harboring candidate oncogenes and tumor suppressor genes. Current efforts aim to explore the functional role and clinical significance of these gene copy number alterations in cancer.

Stanford Medicine Resources:

Footer Links: